146 related articles for article (PubMed ID: 28408242)
1. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.
Rockman S; Lowther S; Camuglia S; Vandenberg K; Taylor S; Fabri L; Miescher S; Pearse M; Middleton D; Kent SJ; Maher D
EBioMedicine; 2017 May; 19():119-127. PubMed ID: 28408242
[TBL] [Abstract][Full Text] [Related]
2. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Baras B; de Waal L; Stittelaar KJ; Jacob V; Giannini S; Kroeze EJ; van den Brand JM; van Amerongen G; Simon JH; Hanon E; Mossman SP; Osterhaus AD
Vaccine; 2011 Mar; 29(11):2120-6. PubMed ID: 21238573
[TBL] [Abstract][Full Text] [Related]
3. Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice.
Hohenadl C; Wodal W; Kerschbaum A; Fritz R; Howard MK; Farcet MR; Portsmouth D; McVey JK; Baker DA; Ehrlich HJ; Barrett PN; Kreil TR
Virol J; 2014 Apr; 11():70. PubMed ID: 24739285
[TBL] [Abstract][Full Text] [Related]
4. H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.
Bissel SJ; Wang G; Carter DM; Crevar CJ; Ross TM; Wiley CA
J Virol; 2014 Mar; 88(6):3077-91. PubMed ID: 24371072
[TBL] [Abstract][Full Text] [Related]
5. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.
Stittelaar KJ; Veldhuis Kroeze EJ; Rudenko L; Dhere R; Thirapakpoomanunt S; Kieny MP; Osterhaus AD
Vaccine; 2011 Nov; 29(49):9265-70. PubMed ID: 21945964
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.
Herbreteau CH; Denizot M; Lowther S; Riddell S; Frazer L; Haining J; Arkinstall R; Payne J; Harper J; Johnson D; Pasquier A; Middleton D; Saluzzo JF
Immunotherapy; 2016 Sep; 8(9):1021-32. PubMed ID: 27380317
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
[TBL] [Abstract][Full Text] [Related]
9. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
[TBL] [Abstract][Full Text] [Related]
10. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.
Baras B; Stittelaar KJ; Simon JH; Thoolen RJ; Mossman SP; Pistoor FH; van Amerongen G; Wettendorff MA; Hanon E; Osterhaus AD
PLoS One; 2008 Jan; 3(1):e1401. PubMed ID: 18167560
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
[TBL] [Abstract][Full Text] [Related]
13. Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments.
Ramisse F; Deramoudt FX; Szatanik M; Bianchi A; Binder P; Hannoun C; Alonso JM
Clin Exp Immunol; 1998 Mar; 111(3):583-7. PubMed ID: 9528903
[TBL] [Abstract][Full Text] [Related]
14. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
15. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
Vaccine; 2009 Nov; 27(47):6512-21. PubMed ID: 19729082
[TBL] [Abstract][Full Text] [Related]
16. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
Smith GE; Sun X; Bai Y; Liu YV; Massare MJ; Pearce MB; Belser JA; Maines TR; Creager HM; Glenn GM; Flyer D; Pushko P; Levine MZ; Tumpey TM
Virology; 2017 Sep; 509():90-97. PubMed ID: 28624679
[TBL] [Abstract][Full Text] [Related]
18. A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus.
Röhrs S; Kalthoff D; Beer M
Vaccine; 2014 May; 32(22):2631-6. PubMed ID: 24674664
[TBL] [Abstract][Full Text] [Related]
19. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus.
Qiu H; Andersen H; Tarbet EB; Muhammad FS; Carnelley T; Pronyk R; Barker D; Kodihalli S
Antiviral Res; 2020 Aug; 180():104753. PubMed ID: 32114033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
